Chemoradiation in Cancer Therapy by Hak ChoyChemoradiation in Cancer Therapy by Hak Choy

Chemoradiation in Cancer Therapy

byHak Choy

Paperback | November 19, 2010

Pricing and Purchase Info

$338.96 online 
$412.95 list price save 17%
Earn 1,695 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new specific molecular targeted agents into multimodality therapy in the future.
Title:Chemoradiation in Cancer TherapyFormat:PaperbackDimensions:420 pages, 25.4 × 17.8 × 0.17 inPublished:November 19, 2010Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617373133

ISBN - 13:9781617373138

Look for similar items by category:


Table of Contents

Part I. General/BackgroundChemoradiation: Biological Principles and PerspectivesHak Choy and Robert M. MacRaeFluoropyrimidines as Radiation SensitizersMuhammad Wasif Saif and Robert B. DiasioPart II. Mechanisms of Interaction of Specific Chemotherapeutic Agents with RadiationThe Role of Platinum Complexes in Combined Modality TherapyBeverly A. TeicherTaxanes in Combined Modality TherapyRobert M. MacRae and Hak ChoyCamptothecin Radiation SensitizationTyvin A. RichThe Role of Gemcitabine in Combined Modality TherapyJerome Landry, William Blackstock, Robert M. MacRae, Gary Yang, and Hak ChoyPart III. Clinical ApplicationsChemoradiation Strategies for Patients with Malignant GliomasHeather A. Curry and Walter J. Curran, Jr.Combined Modality Strategies in the Treatment of Head and Neck CancerCathy Eng and Everett E. VokesThe Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung CancerRoger W. ByhardtCombined Modality Treatment of Small-Cell Lung CancerJulie R. Brahmer, Larry Kleinberg, and David S. EttingerThe Role of Chemoradiation in the Management of Esophageal CancerArlene Forastiere and Bapsi ChakCombined Modality Therapy in Locally Advanced Breast CancerSilvia C. Formenti and Matthew VolmCombined Modality Therapy for Gastric, Pancreatic, and Biliary Tract CarcinomasAlexandria Phan and Jaffer A. AjaniChemoradiation in Therapy for Colon and Rectum CarcinomaJason H. Lee and Christopher G. WillettChemoradiotherapy in Muscle-Invasive Bladder CancerBruce J. RothThe Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic MalignanciesPatricia J. EifelPart IV. Specific Molecular Targeted AgentsOverview of Specific Molecular Targeted Agents for Combined Modality TherapyScott Saxman and Janet DanceyReceptor Tyrosine Kinases as Therapeutic Targets in Solid TumorsStacy L. Moulder and Carlos L. ArteagaAdenoviral p53 Gene Therapy Strategies in Nonsmall-Cell Lung CancerStephen G. Swisher and Jack A. RothTumor Microvasculature as a Therapeutic Target During RadiotherapyDennis E. Hallahan and Don StacyCancer Drug Discovery and Development: Maximizing the Therapeutic Potential of Matrix Metalloproteinase Inhibitors for the Treatment of CancerJeffrey S. Humphrey, Karen Price, Elora Gupta, Andrew Baxter, John Bird, Daryl Sonnichsen, and Joseph NaglichThe Role of Cyclooxygenase-2 Inhibitors in Combined Modality TherapyHong Pyo, Raymond N. DuBois, and Hak ChoyIndex

Editorial Reviews

"Chemoradiaton in Cancer Therapy offers both clinical and basic oncologists not only a bold synthesis of the rapid and complex advances in new therapeutic modalities, but also highly practical guide to today's best strategies in cancer treatment." -Neoplasma